Article
September 16, 2022
For World Alzheimer’s Month, researchers talk about their work and hopes of finding new treatments for this debilitating disease
Alzheimer’s Disease
Neurological Disease
Gladstone in the News
September 10, 2022
San Francisco Chronicle—New COVID-19 booster shots targeting both the ancestral virus and omicron strains are now available. Gladstone Investigator Nadia Roan weighs in on when people should get the jab, based on the timing of their last dose and whether they’ve been recently infected.
Gladstone Experts
COVID-19
Virology
Roan Lab
Gladstone in the News
September 1, 2022
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, says that it makes more sense to boost immunity with the newly approved bivalent vaccines targeting Omicron than with vaccines that aim at long-extinct variants of the coronavirus.
Gladstone Experts
COVID-19
Center for HIV Cure Research
Virology
Greene Lab
Gladstone in the News
August 29, 2022
Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, comments on breakthrough technology developed in his lab that will greatly facilitate the large-scale engineering of immune cells for cell-based therapies.
Gladstone Experts
Genomic Immunology
Marson Lab
CRISPR/Gene Editing
Gladstone in the News
August 12, 2022
Wired—Measuring which genes are on and which are off in a cell usually requires killing it, meaning any measurement is simply a snapshot in time. Seth Shipman explains how his lab has circumvented this problem by re-engineering parts of a bacterial immune system to create a record of molecular events within a cell.
Gladstone Experts
Data Science and Biotechnology
Shipman Lab
CRISPR/Gene Editing
Article
August 2, 2022
Brianne Dotson breaks down what unconscious bias is and how we can mitigate it in the workplace
People Services
Diversity